NCT02558218View on ClinicalTrials.gov

Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Cataract
Interventions
DRUG

Systane Ultra

Further to standard medication (tobradex quid for 20 days), participants were administered Systane Ultra quid for 2 months

DRUG

tobradex quid (Standard)

Standard medication (tobradex quid for 20 days)

Trial Locations (1)

68100

Eye Institute Of thrace, Alexandroupoli

All Listed Sponsors
lead

Democritus University of Thrace

OTHER

NCT02558218 - Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery | Biotech Hunter | Biotech Hunter